SCHEMBL4829803

SCHEMBL4829803

O=C1C2C(C(=O)N1OS(=O)(=O)c1ccccc1)C1C(=O)N(OS(=O)(=O)c3ccccc3)C(=O)C21

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 2/20 0.65
ALDH1A1 P00352 11/20 0.62
KDM4E B2RXH2 6/20 0.62
KMT2A Q03164 5/20 0.62
MAPT P10636 5/20 0.62
HPGD P15428 5/20 0.62
MEN1 O00255 3/20 0.53
HTT P42858 1/20 0.53
VDR P11473 2/20 0.49
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
F2 P00734 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.39
HTR6 P50406 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4827225 0.90 PARL (0.57) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL22251615 0.85 ALDH1A1 (0.64) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL13583550 0.85 PARL (0.57) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL14569437 0.85 PARL (0.61) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL3868687 0.84 PARL (0.55) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL4837033 0.84 PARL (0.64) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL4829793 0.83 KMT2A (0.60) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL4831794 0.81 PARL (0.43) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL4834508 0.81 KDM4E (0.54) PARLALDH1A1KDM4EKMT2AMAPT
SCHEMBL4827161 0.81 VDR (0.63) PARLALDH1A1KDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 PARL 1086/4885ALDH1A1 633/4885KDM4E 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.